REGULUS THERAPEUTICS
CUSIP 7915K2000
Regulus Therapeutics has 1 institutional holders in Filings Flow’s 13F database, together reporting 675 shares worth $0 as of Q2 2023.
Institutional Holders
1
Q2 2023
Reported Value
$0
Ticker
unmapped
private placement or foreign
Quarters Tracked
5
Ownership Trend
Institutional holders
Total reported value
Holders
··
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| Endurance Wealth Management, Inc.$731M AUM | — | $0 | 675 | Q2 2023 |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.